Gland Pharma Ltd banner

Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 658.3 INR 1.49% Market Closed
Market Cap: ₹273.2B

Profitability Summary

Gland Pharma Ltd's profitability score is 51/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score
51/100
Profitability
Score

Margins

Earnings Waterfall
Gland Pharma Ltd

Margins Comparison
Gland Pharma Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Gland Pharma Ltd
NSE:GLAND
273.2B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
861.5B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.5B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.1B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
283.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.7B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Gland Pharma Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Gland Pharma Ltd
NSE:GLAND
273.2B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
861.5B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
283.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.7B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Gland Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett